Factors leading to high morbidity and mortality of COVID‐19 in patients with type 2 diabetes

A Rajpal, L Rahimi, F Ismail‐Beigi - Journal of diabetes, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is a recent pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a novel coronavirus. Diabetes …

DPP4 and ACE2 in diabetes and COVID-19: therapeutic targets for cardiovascular complications?

I Valencia, C Peiro, O Lorenzo… - Frontiers in …, 2020 - frontiersin.org
COVID-19 outbreak, caused by severe acute respiratory syndrome (SARS)-CoV-2
coronavirus has become an urgent health and economic challenge. Diabetes is a risk factor …

Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the …

G Fiorentino, A Coppola, R Izzo, A Annunziata… - …, 2021 - thelancet.com
Background We and others have previously demonstrated that the endothelium is a primary
target of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and L …

[HTML][HTML] Diabetes mellitus and COVID-19: understanding the association in light of current evidence

S Sen, R Chakraborty, P Kalita… - World journal of clinical …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have posed a
problematic healthcare situation worldwide since December 2019. Diabetes mellitus is …

A machine-generated view of the role of blood glucose levels in the severity of COVID-19

E Logette, C Lorin, C Favreau, E Oshurko… - Frontiers in Public …, 2021 - frontiersin.org
SARS-CoV-2 started spreading toward the end of 2019 causing COVID-19, a disease that
reached pandemic proportions among the human population within months. The reasons for …

A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng

Y Liu, H Zhang, X Dai, R Zhu, B Chen, B Xia, Z Ye… - Phytomedicine, 2021 - Elsevier
Abstract Background Radix Ginseng, one of the well-known medicinal herbs, has been used
in the management of diabetes and its complications for more than 1000 years. Purpose The …

COVID-19 and diabetes: What does the clinician need to know?

E Papadokostaki, N Tentolouris, E Liberopoulos - Primary care diabetes, 2020 - Elsevier
COVID-19 and diabetes are currently two global pandemics. Epidemiological studies
indicate that diabetes is the second most common comorbidity in COVID-19. This review …

Breathlessness and COVID-19: a call for research

L Hentsch, S Cocetta, G Allali, I Santana, R Eason… - Respiration, 2021 - karger.com
Breathlessness, also known as dyspnoea, is a debilitating and frequent symptom. Several
reports have highlighted the lack of dyspnoea in a subgroup of patients suffering from …

Diabetic pneumopathy–a new diabetes-associated complication: mechanisms, consequences and treatment considerations

S Kopf, V Kumar, Z Kender, Z Han, T Fleming… - Frontiers in …, 2021 - frontiersin.org
Patients with diabetes are over-represented among the total cases reported with “idiopathic”
pulmonary fibrosis (IPF). This raises the question, whether this is an association only or …

Clinical management of diabetes mellitus in the era of COVID-19: practical issues, peculiarities and concerns

C Koliaki, A Tentolouris, I Eleftheriadou… - Journal of clinical …, 2020 - mdpi.com
The management of patients with diabetes mellitus (DM) in the era of the COVID-19
pandemic can be challenging. Even if they are not infected, they are at risk of dysregulated …